Nick Yoder
Executive Director Dyne Therapeutics
Seminars
Thursday 19th March 2026
Looking Beyond Oncology: Investigating Development & Delivery of AOCs Against Neuromuscular Disorders
11:30 am
- Exploring the FORCE modular drug delivery approach to enable widespread distribution of AOCs and chemically diverse therapeutic payloads to muscle and the CNS
- Assessing clinical data from DYNE-101 ACHIEVE trial in patients with DM1 and DYNE-251 DELIVER trial against DMD
- Contextualising how the encouraging clinical data and preclinical efficacy in FSHD and Pompe models supports the potential of FORCETM and AOCs to address neuromuscular disorders with high unmet medical needs
